39.82
1.32%
+0.52
전일 마감가:
$39.30
열려 있는:
$39.56
하루 거래량:
820.11K
시가총액:
$5.06B
수익:
$829.25M
순이익/손실:
$281.59M
주가수익비율:
21.18
EPS:
1.88
순현금흐름:
$373.28M
1주 성능:
+3.54%
1개월 성능:
-1.51%
6개월 성능:
+16.26%
1년 성능:
+25.14%
Halozyme Therapeutics Inc. Stock (HALO) Company Profile
명칭
Halozyme Therapeutics Inc.
전화
858-794-8889
주소
11388 Sorrento Valley Road, San Diego, CA
Halozyme Therapeutics Inc. Stock (HALO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-07-24 | 다운그레이드 | Goldman | Buy → Neutral |
2023-07-24 | 개시 | H.C. Wainwright | Buy |
2023-05-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2023-03-27 | 재개 | Berenberg | Buy |
2023-03-16 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
2022-12-21 | 재개 | Morgan Stanley | Overweight |
2022-11-28 | 개시 | Wells Fargo | Overweight |
2022-09-09 | 개시 | Morgan Stanley | Overweight |
2022-05-23 | 개시 | SVB Leerink | Outperform |
2021-06-14 | 개시 | Evercore ISI | Outperform |
2021-05-17 | 개시 | SVB Leerink | Outperform |
2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-01-21 | 재확인 | The Benchmark Company | Buy |
2020-12-17 | 개시 | Berenberg | Buy |
2020-09-14 | 재개 | JP Morgan | Overweight |
2020-07-01 | 개시 | The Benchmark Company | Buy |
2020-02-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2020-01-09 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2020-01-08 | 개시 | Goldman | Buy |
2019-11-05 | 업그레이드 | Barclays | Underweight → Equal Weight |
2018-10-19 | 재개 | Piper Jaffray | Neutral |
2018-05-11 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2018-01-24 | 개시 | Goldman | Neutral |
2017-10-16 | 재확인 | Piper Jaffray | Overweight |
2017-01-06 | 다운그레이드 | Citigroup | Buy → Neutral |
2016-11-03 | 개시 | Deutsche Bank | Buy |
2015-12-04 | 개시 | Wells Fargo | Outperform |
2015-11-18 | 개시 | Citigroup | Buy |
2015-09-22 | 개시 | Barclays | Overweight |
2015-06-22 | 재확인 | JP Morgan | Overweight |
2015-03-03 | 재확인 | UBS | Buy |
2015-02-18 | 재확인 | MLV & Co | Buy |
2015-01-08 | 재확인 | MLV & Co | Buy |
모두보기
Halozyme Therapeutics Inc. 주식(HALO)의 최신 뉴스
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Zacks Investment Research
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Zacks Investment Research
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Zacks Investment Research
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research
9 Analysts Have This To Say About Halozyme Therapeutics
Benzinga
Halozyme Therapeutics Inc. (HALO) 재무 분석
Halozyme Therapeutics Inc. (HALO) 매출 2024
HALO은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 829.25M 달러로 보고했으며, 전년대비 +25.62% 상승했습니다.
Halozyme Therapeutics Inc. (HALO) 순이익 2024
HALO은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 281.59M 달러로 보고했으며, 전년대비 +39.31% 증가했습니다.
Halozyme Therapeutics Inc. (HALO) 현금흐름 2024
2023-12-31 종료 분기에 HALO은 현금흐름(지난 12개월)으로 373.28M 달러를 기록했으며, 전년 대비 +58.64% 증가했습니다.
Halozyme Therapeutics Inc. (HALO) 주당 순이익 2024
HALO이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 2.11달러이며, 전년 대비 +45.52% 성장했습니다.
Halozyme Therapeutics Inc. 주식 (HALO) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Apr 17 '24 |
Option Exercise |
8.11 |
10,000 |
81,100 |
178,176 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Apr 17 '24 |
Sale |
38.49 |
10,000 |
384,890 |
168,176 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Apr 16 '24 |
Option Exercise |
8.11 |
10,000 |
81,100 |
178,176 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Apr 16 '24 |
Sale |
38.35 |
10,000 |
383,500 |
168,176 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Mar 26 '24 |
Option Exercise |
11.20 |
11,618 |
130,160 |
168,176 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Mar 13 '24 |
Option Exercise |
10.66 |
10,000 |
106,638 |
166,558 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Mar 13 '24 |
Sale |
42.27 |
10,000 |
422,730 |
156,558 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Mar 12 '24 |
Option Exercise |
12.07 |
10,000 |
120,700 |
166,558 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Mar 12 '24 |
Sale |
41.64 |
10,000 |
416,370 |
156,558 |
LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Feb 28 '24 |
Option Exercise |
8.11 |
7,471 |
60,590 |
164,029 |
자본화:
|
볼륨(24시간):